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Purpose:  Obesity  is  a  major  public  health  problem  worldwide,  and  of  late,  epidemiological  studies  indicate  a
preponderance of cataracts under obesity conditions. Although cataract is a multifactorial disorder and various biochemical
mechanisms have been proposed, the influence of obesity on cataractogenesis has yet to be investigated. In such a scenario,
a suitable animal model that develops cataract following the onset of obesity will be a welcome tool for biomedical
research. Therefore, we investigated the molecular and biochemical basis for predisposition to cataract in the obese mutant
rat models established in our institute because 15%–20% of these rats develop cataracts spontaneously as they reach 12–
15 months of age.
Methods: We analyzed the major biochemical pathways in the normal lenses of different age groups of our obese mutant
rat strains, Wistar/Obese (WNIN/Ob) and WNIN/GR-Ob, the former with euglycemia and the latter with an additional
impaired glucose tolerance trait. In addition, sorbitol levels were estimated in the cataractous lenses of the obese rats.
Results: Except for the polyol pathway, all the principal pathways of the lens remained unaltered. Therefore, sorbitol
levels were found to be high in the normal eye lenses of obese rats (WNIN/Ob and WNIN/GR-Ob) compared to their lean
controls from three months of age onwards. Between WNIN/Ob and WNIN/GR-Ob, the levels of sorbitol were higher in
the latter, suggesting a synergistic effect of impaired glucose tolerance along with obesity in the activation of the sorbitol
pathway. Either way, an elevated sorbitol pathway seemed to be the predisposing factor responsible for cataract formation
in these mutant rats.
Conclusions: Activation of the sorbitol pathway indeed enhances the risk of cataract development in conditions such as
metabolic syndrome. These rat models thus may be valuable tools for investigating obesity-associated cataract and for
developing intervention strategies, based on these findings.
Epidemiological  studies  suggest  the  prevalence  of
overweight  and  obesity  has  reached  epidemic  proportions
worldwide [1], and in the past 20 years, obesity rates have
tripled in developing countries as well [2,3]. Several serious
medical conditions are now associated with obesity, and it is
no longer considered just a problem of overweight. Obesity is
now  aptly  referred  to  as  a  metabolic  syndrome  and  is
associated  with  several  degenerative  diseases,  including
coronary heart disease, type 2 diabetes, hypertension, stroke,
dyslipidemia,  osteoarthritis,  sleep  apnea,  fatty  liver,  and
certain types of cancers. Eye problems are probably the latest
addition to this list associated with obesity [4,5]. The ocular
complications of obesity include diabetic retinopathy, high
intraocular  pressure,  cataracts,  macular  degeneration,  and
exophthalmos [4,5].
Cataract is the leading cause of blindness worldwide and
accounts for an estimated 16 million cases of blindness, with
approximately half of all cases originating in Africa and Asia
[6,7]. Recently, several large population-based studies have
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shown the association between obesity and cataract [5,8-12].
For example, the Physicians’ Health Study [9,12], the Nurses’
Health Study [10], and the Framingham Eye Study [11], as
well as several cross-sectional studies [13-16], demonstrated
a positive association between various measures of obesity
and cataract. Cortical and posterior subcapsular cataracts have
been most consistently associated with obesity [13,15-17]. In
the Age-Related Eye Disease Study (AREDS), higher body
mass  index  (BMI)  and  weight  gain  were  found  to  have
significant association with moderate cortical cataract [17].
There are three principal mechanisms by which the lens
can  be  damaged,  resulting  in  cataract  (oxidative  stress,
osmotic effect, and non-enzymatic protein glycation [18]),
and obesity might influence any or all of these physiologic
processes [19,20]. However, to the best of our knowledge no
experimental studies have explained the association between
obesity and cataract and their plausible pathophysiological
mechanism(s). Thus, there is an urgent need for mechanistic
studies  to  understand  cataract  due  to  obesity.  In  such  a
scenario, the availability of an animal model that develops
cataract  following  the  onset  of  obesity  (akin  to  obesity-
associated cataract in patients) is of immense value.
At the National Center for Laboratory Animal Sciences
of our institute, as early as 1997, a spontaneously developed
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495obese rat was isolated from the existing Wistar (WNIN) stock
of rats, and a colony of WNIN-Obese (WNIN/Ob) rats was
established by selective breeding [21,22]. Subsequently, it
bifurcated into another strain with impaired glucose tolerance
(IGT)-WNIN/GR-Ob [21,23]. The phenotype and associated
biochemical,  histological,  and  pathophysiological
characteristics  of  WNIN/Ob  and  WNIN/GR-Ob  rats  have
been reported in detail elsewhere [21-24]. In essence, starting
from 35 to 40 days of age, the WNIN/Ob and WNIN/GR-Ob
phenotypes are different from their respective lean littermates,
and the rats’ bodyweight increases progressively until the age
of six to nine months. The average life span of these obese
mutant rat strains was found to be 18–24 months as against
30–36 months for their parent WNIN strain. The animals show
hyperinsulinemia,  hypertriglyceridemia,  and
hypercholesterolemia. In addition, these rats also seem to
develop  a  few  degenerative  conditions  such  as  retinal
degenerations as early as four months of age [25]. Further, our
initial screening of these rat colonies showed that about 15%
of  WNIN/Ob  and  20%  of  WNIN/GR-Ob  rats  develop
cataracts spontaneously by the time they reach 12 months of
age. However, the molecular basis for these cataracts was a
dilemma, that, too, being shown in about only 15%–20%
animals at best. We undertook the present study to explore and
explain the observed enigma.
METHODS
Materials:  Anti-α-actin  antibody,  bovine  serum  albumin
(BSA),  1-chloro-2,4-dinitro  benzene  (CDNB),  2,4-dinitro
phenyl hydrazine (DNPH), diethylene triamine penta acetic
acid (DEPTA), glucose-6-phosphate, glutathione reductase,
DL-glyceraldehyde,  glutathione  (GSH),  nicotinamide
adenine dinucleotide (NAD), NADH, nicotinamide adenine
dinucleotide  phosphate  (NADP),  nicotinamide  adenine
dinucleotide phosphate (reduced) (NADPH), pyrogallol, D-
sorbitol, sorbitol dehydrogenase, antirabbit immunoglobulin
G (whole molecule) peroxidase, and Tris-HCl were purchased
from Sigma Chemicals (St. Louis, MO). The Sephacryl S-300
HR was from Amersham Biosciences (Piscataway, NJ).
Animals and tissue collection: All the procedures involving
rats were performed in accordance with the Association for
Research in Vision and Ophthalmology (ARVO) statement
for the Use of Animals in Ophthalmic and Vision Research
and  were  approved  by  the  Institutional  Animal  Ethics
Committee at the National Institute of Nutrition. Animals
were  kept  in  a  12-h  light-dark  cycle  with  ambient  light
intensity  and  temperature  at  the  National  Center  for
Laboratory Animal Science, National Institute of Nutrition.
Three- to 12-month-old WNIN/Ob and WNIN/GR-Ob rats
along with their respective lean littermate rats were fasted
overnight and sacrificed by CO2 asphyxiation at the end of the
dark cycle.
Slit  lamp  examination  and  lens  collection:  Eyes  were
examined for lens opacity using a slit lamp biomicroscope
(Kowa Portable; Kowa, Ltd., Tokyo, Japan) on dilated pupils.
Only clear lenses without any opacity were used for analysis.
Eyeballs of three- to 12-month-old animals were collected,
and  the  lenses  were  dissected  by  the  posterior  approach.
Briefly, a small incision was made on the posterior side of the
eye with scissors. The lenses were collected by pressing with
tweezers against the side of the eye opposite the incision and
stored at −70 °C until further analysis.
Protein  solubility,  crystallin  distribution,  protein  cross-
linking, and protein aggregation: A 10% homogenate of the
lenses was prepared in homogenization buffer (25 mM Tris-
Cl, pH 8.0 containing 0.5 mM ethylenediaminetetraacetic acid
and  100  mM  NaCl).  The  homogenate  was  centrifuged  at
10,000× g for 30 min at 4 °C. The supernatant was referred to
as the soluble fraction. Total and soluble protein content was
estimated  with  the  Lowry  method,  and  the  percentage  of
soluble  protein  was  calculated.  The  soluble  fraction  was
applied onto a 300× 7.8 mm TSK-3000 SW-XL size exclusion
chromatography (SEC) column (Tosoh Co., Tokyo, Japan)
using a Shimadzu high-performance liquid chromatography
system [26]. The subunit profile and cross-linking of lens-
soluble proteins were analyzed on 12% polyacrylamide gels
in  the  presence  of  sodium  dodecyl  sulfate  (SDS)  under
reducing conditions [27].
Oxidative stress and antioxidant defense system: Lens lipid
peroxidation was measured as thiobarbituric acid reacting
substances  (TBARS)  and  protein  carbonyl  content  was
determined based on their reactivity with 2,4-dinitrophenyl
hydrazine according to reported methods [27-29]. In brief,
malondialdehyde is the end product of lipid peroxidation of
polyunsaturated fatty acids. Malondialdehyde was estimated
by utilizing its reactivity with 2-thiobarbituric acid resulting
pink coloured condensation product, a trimethine which was
measured spectrophotometrically at 533 nm. The carbonyls
react  with  2,4-dinitrophenyl  hydrazine  to  form  protein
hydrozones,  which  can  be  detected  and  quantified
spectrophotometrically  at  365  nm.  The  activities  of
antioxidant  enzymes:  superoxide  dismutase  (SOD),
glutathione  peroxidase  (GPx),  glutathione  S-transferase
(GST) and glucose-6-phosphate dehydrogenase (G6PD) were
assayed  spectrophotometrically  according  to  the  reported
methods [27,29]. The assay of SOD is based on the ability of
the enzyme to inhibit the auto-oxidation of pyrogallol. The
rate of auto-oxidation of pyrogallol is measured following the
change in absorbance at 420 nm. GPx catalyzes the oxidation
of  reduced  glutathione  by  hydrogen  peroxide  or  lipid
peroxides to oxidized glutathione (GSSG). The rate of GSSG
formation,  a  measure  of  enzyme  activity,  was  monitored
coupling  with  the  glutathione  reductase  reaction  where
NADPH oxidation was followed at 340 nm. GST catalyzes
the  conjugation  of  toxic  electrophilic  compounds  with
glutathione.  In  GST  assay  formation  of  1-chloro-2,4-
dinitrobenzene-glutathione conjugate was monitored at 340
nm. G6PD catalyzes the oxidation of glucose-6-phosphate to
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4966- phosphogluconolactone in presence of NADP+. The rate
of NADP reduction to NADPH was followed as a measure of
enzyme activity of G6PD at 340 nm.
Non-enzymatic  glycation:  The  extent  of  glycation  was
measured  by  monitoring  advanced  glycation  end-product
(AGE)  related  non-tryptophan  fluorescence.  AGE
fluorescence measurements were performed using a Jasco
spectrofluorometer  (FP-6500;  Tokyo,  Japan)  in  soluble
protein (0.15 mg/ml protein in 50 mM sodium phosphate
buffer, pH 7.2) [28]. Fluorescence spectra were obtained from
400 to 500 nm with excitation at 370 nm.
Polyol pathway: The status of the polyol pathway in the eye
lenses of WNIN/Ob and WNIN/GR-Ob rats was assessed by
analyzing the activity of aldose reductase (ALR2) and sorbitol
dehydrogenase (SDH) and sorbitol levels in the lens. The
activities  of  ALR2  and  SDH  were  assayed
spectrophotometrically  according  to  the  reported  methods
[27,29].  ALR2  catalyzes  the  NADPH  linked  reduction  of
glyceraldehyde and change in the absorbance at 340 nm due
to NADPH oxidation was monitored. SDH catalyses the NAD
linked oxidation of sorbitol to fructose or reduction of fructose
to sorbitol. SDH activity was measured by the decrease in
absorbance at 340 nm due to the oxidation of NADH using
fructose  as  the  substrate..  Sorbitol  was  extracted  by
homogenizing the lens in nine volumes of 0.8 M perchloric
acid. The homogenate was centrifuged at 5,000× g at 4 °C for
10 min, and the pH of the supernatant was adjusted to 3.5 with
0.5  M  potassium  carbonate.  The  sorbitol  content  of  the
supernatant was measured with the fluorometric method as
described  previously  [30]  using  a  fluorometer  (Jasco-
FP-6500, Tokyo, Japan). One ml reaction mixture, consisted
of  50  μmol  glycine  buffer,  pH  9.4,  2  μmol  magnesium
chloride, 0.2 μmol nicotinamide adenine dinucleotide (NAD)
and protein-free supernatant, was incubated for 5 min at 37 °C,
and the reaction was initiated by the addition of 0.6 U of SDH.
The  relative  fluorescence  due  to  NADH  formation  was
measured in a fluorometer with an excitation wavelength at
360 nm and an emission wavelength of 452 nm. Sorbitol
standards, ranging from 0.2 to 9.0 μg/ml, were analyzed the
same way to generate a standard curve. Sorbitol was also
estimated in a few cataractous lenses collected from the obese
rats.
Immunodetection of ALR2 in the soluble fraction of lens:
Lens-soluble  proteins  were  resolved  under  reducing
conditions on 12% SDS–polyacrylamide gel electrophoresis
(PAGE),  proteins  were  transferred  onto  a  nitrocellulose
membrane (NC), and NC was blocked with 5% skimmed milk
powder. The NC membrane was incubated with an affinity
purified polyclonal antisera of ALR2 (1:2,000 dilution) later
with  horseradish  peroxidase–conjugated  goat  antirabbit
antibody (1:2,500). Subsequently, detection was performed
with diaminobenzidine in the presence of hydrogen peroxide.
Statistical analysis: Descriptive statistics were calculated for
all the study variables, and a t test was used to compare the
mean values of different parameters among groups for given
age/strain. Mean values were also compared among the time
points for given group/strain using ANOVA with a post hoc
Fisher’s least significant difference test. Level of significance
was considered as 0.05.
RESULTS AND DISCUSSION
Protein content: Insolubilization and aggregation of soluble
lens proteins is the major biochemical alteration leading to
cataractogenesis.  Therefore,  we  determined  the  total  and
soluble  protein  content  in  the  lens  of  the  WNIN/Ob  and
WNIN/GR-Ob rats at different ages. Although irrespective of
phenotypes there was a decrease in soluble protein content
with age, there was no difference in protein (total, soluble, and
insoluble) content of the WNIN/Ob rats as compared to lean
rats of the corresponding age (Table 1). Similar results were
observed with WNIN/GR-Ob rats (data not shown).
Crystallin distribution and protein cross-links: To understand
the possible alterations in crystallin distribution and subunit
profile  due  to  obesity,  the  soluble  protein  fraction  was
analyzed  with  SEC  and  SDS–PAGE.  The  lens-soluble
fraction  was  clearly  resolved  into  high  molecular  weight
aggregate-, αL-, β-, and γ-crystallin peaks on a SEC column,
and there was no difference in the percentage distribution of
different  crystalline  peaks  between  WNIN/Ob  and  its
respective lean animals from three to 12 months (Figure 1).
TABLE 1. PROTEIN CONTENT OF EYE LENS.
Age (months) Group Total protein (mg/g lens) Soluble protein (mg/g lens) Soluble protein (%)
3 Lean 502.8±15.81 389.2±19.57 77.54±2.999
  Obese 497.4±15.05 381.7±11.99 77.17±2.517
6 Lean 573.0±12.64 391.7±11.44 68.34±1.319
  Obese 564.5±16.73 379.8±14.01 67.36±1.507
12 Lean 612.4±15.04 369.1±10.09 60.33±1.208
  Obese 619.6±28.71 356.6±8.12 58.19±1.958
        The total and soluble protein in the lens of WNIN/Ob rats of different age was estimated by Lowry’s method and the percentage
        soluble protein content was derived from the estimated values. Data are mean±SE (n=6).
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497Similar results were observed with WNIN/GR-Ob rats (data
not shown). Similarly, the subunit profile of lens proteins and
cross-linking was also not different in WNIN/Ob or WNIN/
GR-Ob  rats  compared  to  their  respective  lean  animals  as
assessed with SDS–PAGE (Figure 2).
Oxidative  stress  and  the  antioxidant  system:  Increased
oxidative stress has been implicated in the development of
various  types  of  cataract  [31-34].  Therefore,  we  assessed
oxidative  stress  by  measuring  lipid  peroxidation,  protein
carbonyls, and some of the antioxidant enzymes in the lenses
of WNIN/Ob and WNIN/GR-Ob rats. The TBARS levels, an
indication  of  lipid  peroxidation,  were  not  different  in  the
WNIN/Ob  or  WNIN/GR-Ob  lenses  compared  with  their
respective lean controls from three to 12 months (data not
shown). Usually, increased lipid peroxidation is observed in
hypercholesterolemia  and  hyperlipidemia.  Although  the
obese rats were hypercholesterolemic and hyperlipidemic, we
did not observe any change in the lipid peroxidation of the
lenses between the lean and obese rats suggesting that the lens
might have a robust mechanism to preserve and maintain the
fatty acids profile even under altered metabolic conditions.
Because  we  observed  a  significant  increase  in  lipid
peroxidation (TBARS) in other tissues such as the livers,
hearts, and kidneys of the WNIN/Ob and WNIN/GR-Ob rats
compared with their respective lean animals (data not shown).
Further, there were no significant differences in the fatty acid
composition of the lenses between the lean and WNIN-Ob rats
(data not shown), which indicates that indeed the eye lens has
a robust mechanism for preserving and maintaining the fatty
acids profile under altered metabolic conditions.
Figure 1. Profile of crystallin distribution in WNIN/Ob rat lens.
Representative distribution profile of eye lens crystallins in soluble
fraction of lean and WNIN/Ob rats. Soluble protein (20 μl, 1 mg/ml
in  equilibration  buffer)  was  loaded  on  TSK-G3000  SWXL  gel
filtration column and protein peaks were detected at 280 nm with a
flow rate of 1 ml/min. Peaks representing alpha (α-), betaH (βH-),
betaL (βL-), and gamma (γ-) crystallin, and high molecular weight
(HMW) fractions are indicated at their respective positions.
However,  we  found  the  protein  carbonyl  content,  a
measure of oxidative damage to proteins, higher in the WNIN/
Ob  and  WNIN/GR-Ob  rat  lenses  compared  with  their
respective  lean  controls  suggesting  enhanced  protein
oxidation in the obese rat lens (Figure 3). The increase in
protein oxidation due to obesity was more prominent in the
WNIN/GR-Ob  rat  lenses  compared  to  the  WNIN/Ob  rat
lenses (Figure 3) indicating the added effect of IGT. Similarly,
there  was  an  increase,  though  statistically  not  significant,
specifically  SOD,  GPx,  G6PD,  and  GST  activities  in  the
Figure 2. Subunit profile of lens proteins of WNIN/Ob and WNIN/
GR-Ob rat. Representative subunit profile and protein cross-linking
of the soluble fraction of lens of WNIN/Ob (top panel) and WNIN/
GR-Ob rats (bottom panel) at different ages. Soluble lens protein was
resolved on a 12% polyacrylamide gel under reducing conditions.
Lane 1: molecular weight markers, lane 2: lean (3-months), lane 3:
lean (6-months), lane 4: lean (12-months), lane 5: obese (3-months),
lane 6: obese (6-months) and lane 7: obese (12-months).
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498lenses of WNIN/Ob and WNIN/GR-Ob animals compared
with their respective lean animals at three, six, and 12 months,
thereby substantiating the increased oxidative stress in the eye
lens due to obesity (Table 2).
Non-enzymatic glycation: Non-enzymatic glycation of lens
protein has been considered a major factor responsible for age-
related and diabetic cataracts [35,36], which alters protein
conformation and stability, induces protein aggregation and
cross-linking, and leads to protein insolubilization [37-39].
Hence, the degree of glycation in the soluble and insoluble
Figure 3. Protein carbonyl content in soluble protein fraction of
WNIN/Ob (top panel) and WNIN/GR-Ob rats (bottom panel) at
different ages. Data are mean±SE (n=6). The asterisk (*) above the
bars denotes that data are significantly different between lean and
obese rats at the respective age.
protein fraction of the WNIN/Ob and WNIN/GR-Ob animals
was measured by monitoring AGE-related non-tryptophan
fluorescence.  However,  there  was  no  difference  in  AGE-
related non-tryptophan fluorescence between WNIN/Ob and
WNIN/GR-Ob  and  the  respective  lean  rats  in  all  the  age
groups studied (data not shown). The lack of change in the
subunit profile and cross-linking of lens proteins in WNIN/
Ob or WNIN/GR-Ob rats compared to their respective lean
animals (Figure 2) further corroborate these observations.
Polyol  pathway:  Among  the  many  biochemical  pathways
associated  with  cataract,  the  polyol  pathway  has  been
extensively studied, particularly in the diabetic cataract [29,
34,40,41]. Hence, we investigated the status of the polyol
pathway  in  WNIN/Ob  and  WNIN/GR-Ob  rat  lenses.  The
specific activity of ALR2, the rate-limiting enzyme of the
polyol pathway, was moderately but consistently higher in the
lenses of WNIN/Ob and WNIN/GR-Ob animals from three
months  of  age  onwards  compared  to  the  respective  lean
animals (Table 3). However, the activity of SDH, the second
enzyme of the polyol pathway, was not altered significantly
in obese rats (data not shown). Yet there was a remarkable
increase in sorbitol, the product of ALR2, in the lenses of the
WNIN/Ob  and  WNIN/GR-Ob  rats  when  compared  to
respective lean animals from three months of age onwards
(Figure 4). The increase in sorbitol levels was greater in the
WNIN/GR-Ob rats compared to the WNIN/Ob rats for the
corresponding age groups, and the increase was higher in
older animals (Figure 4). This further indicates a synergistic
effect of IGT along with obesity on the activation of the
sorbitol pathway. Increased levels of sorbitol were consistent
with the increased bodyweight as sorbitol levels were highly
correlated with bodyweight with a correlation coefficient of
0.958  (p<0.001;  Figure  5).  This  suggests  that  BMI
(overweight or obesity) has a direct influence on sorbitol
levels.
For a moderate increase in ALR2 activity, the increase in
sorbitol levels was substantial in the WNIN/Ob lenses and
more so in the WNIN/GR-Ob rat lenses. Therefore, we then
TABLE 2. ACTIVITY OF ANTIOXIDANT ENZYMES.
Age (months) Group SOD GPx G6PD GST
3 Lean 28.42±2.675 22.83±1.467 7.38±0.717 32.88±1.826
  Obese 30.42±2.383 24.34±1.131 8.19±0.681 35.07±3.433
6 Lean 31.20±2.028 21.04±1.581 7.37±0.455a 27.20±1.382
  Obese 33.10±2.303 23.63±2.207 9.39±0.599b 26.13±2.064
12 Lean 32.1±2.972 21.87±1.665 6.19±0.392a 32.77±2.227
  Obese 38.08±2.519 25.92±0.912 7.39±0.249b 34.22±1.561
         Activity of superoxide dismutase (SOD), glutathione peroxidase (GPx), glucose-6-phosphate dehydrogenase (G6PD), and
         glutathione-S-transferase  (GST)  in  the  eye  lens  of  WNIN/Ob  rats  of  different  age.  Data  are  mean±SE  (n=6).  Different
         superscripts denote that data are significantly different between lean and obese rats at the respective age. Specific activity was
         expressed as Units/100 mg protein (SOD) or μmoles NADPH oxidized/h/100mg protein (GPx) or μmoles NADP reduced/h/
         100 mg protein (G6PD) or μmoles GSH-CDNB conjugate formed/h/100 mg protein (GST).
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499determined  the  expression  of  ALR2  in  the  lens  with
immunodetection using ALR2-specific polyclonal antibodies
[42]. The data indicate ALR2 expression was higher in the
lenses of WNIN/Ob and WNIN/GR-Ob rats compared to lean
animals (Figure 6). The increase in transcript levels (analyzed
with real-time polymerase chain reaction) also supports the
western data (data not shown).
Figure 4. Sorbitol levels in the eye lens of WNIN/Ob (top panel) and
WNIN/GR-Ob rats (bottom panel) at different ages. Data are mean
±SE (n=6). The asterisk (*) above the bars denotes that data are
significantly different between lean and obese rats at the respective
age.
Apart from the major biochemical pathways, chaperone-
like activity (CLA) of α-crystallin was also assessed, as the
CLA of α-crystallin has been shown to play a critical role in
maintaining lens transparency, and loss of CLA of α-crystallin
was observed in many types of cataract [43]. However, there
was no significant difference in the CLA of α-crystallin in the
three- to 12-month-old WNIN/Ob and WNIN/GR-Ob eye
lenses compared to their respective age-matched lean controls
(data not shown).
These results indicate that under normal conditions all
principal lens pathways except the polyol pathway remained
unaltered in these mutant rats. The higher levels of sorbitol in
the lenses of the WNIN/Ob and WNIN/GR-Ob rats could be
attributed to increased specific activity as well as increased
expression of ALR2. Further, there were moderately higher
plasma glucose levels in the WNIN/Ob and WNIN/GR-Ob
rats (Figure 7). Probably these three factors (chronic high
glucose, increased activity, and expression of ALR2) together
might have contributed to substantially high sorbitol levels in
the lenses of the WNIN/Ob and WNIN/GR-Ob rats. Studies
Figure  5.  Correlation  between  body  weight  and  lens  sorbitol  of
WNIN/Ob and WNIN/GR-Ob rats. Correlation (r=0.958) between
eye lens sorbitol levels and body weight of WNIN/Ob and WNIN/
GR-Ob rats and their corresponding lean controls at different ages
was found to be highly significant (p<0.001).
TABLE 3. ALDOSE REDUCTASE ACTIVITY.
  WNIN/Ob WNIN/GR-Ob
Age (months) Lean Obese Lean Obese
3 36.56±1.869 40.08±2.524 37.64±1.313 39.44±2.080
6 37.89±1.639 41.33±1.818 40.40±1.269 43.84±2.383
12 39.68±1.459 43.88±1.855 41.04±1.894 45.16±1.414
        Aldose reductase (ALR2) activity in WNIN/Ob and WNIN/GR-Ob rat lens of different age. Data are mean±SE (n=6). ALR2
        activity was expressed as μmoles NADPH oxidized/h/100 mg protein.
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and oxidative stress [29,34,44]. Therefore, activation of the
polyol  pathway  may  lead  to  increased  oxidative  stress  as
indicated by higher protein carbonyls and altered activities of
antioxidant enzymes in the eye lenses of the WNIN/Ob rats
and more so in the WNIN/GR-Ob rats. These results suggest
that increased sorbitol might be a predisposing factor for the
higher incidence of cataract in WNIN/Ob and WNIN/GR-Ob
rats.
A previous study reported increased sorbitol pathway
activity in the sciatic nerve of the leptin-deficient ob/ob mouse
with mild hyperglycemia that developed peripheral diabetic
Figure 6. Immunodetection of aldose reductase in the eye lens of
WNIN/Ob and WNIN/GR-Ob rats. Western blot of aldose reductase
in the eye lens of WNIN/Ob (left panel) and WNIN/GR-Ob rats (right
panel) at 12-months age. Data are mean±SE (n=6). The asterisk (*)
above the bars denotes that data are significantly different between
lean and obese rats.
Figure 7. Plasma glucose levels of WNIN/Ob and WNIN/GR-Ob rats
at different ages. Data are mean±SE (n=6). The asterisk (*) above
the bars denotes that data are significantly different between lean and
obese rats at the respective age.
neuropathy  (PDN)  at  11  weeks  [45].  Interestingly,
administration of fidarestat, an ALR2 inhibitor, to ob/ob mice
for  six  weeks  was  associated  with  alleviation  of  PDN
pathogenic  features  [45],  suggesting  the  involvement  of
sorbitol in PDN associated with obesity.
Another  study  also  demonstrated  that  prediabetic
neuropathy in mice fed a high-fat diet could be alleviated by
a  dietary  intervention  or  a  combination  of  a  dietary
intervention and pharmacological treatment with an ALR2
inhibitor  [46],  corroborating  the  role  of  sorbitol  in  the
development of obesity associated complications. Increased
accumulation of sorbitol in the retina has been implicated in
the pathogenesis of diabetic retinopathy [30]. Rajala et al.
examined  insulin  receptor  (IR)  signaling  in  the  sorbitol-
treated  retina  under  ex  vivo  conditions  and  showed  that
sorbitol activates the IR and IGF-1R tyrosine kinases, which
results  in  activation  of  the  receptor’s  direct  downstream
targets [47]. Recently we reported a threefold increase in
sorbitol levels in the eye lens (without cataract) in the neonatal
streptozotocin  rat  model  with  prolonged  IGT  and  insulin
resistance [48]. All these studies support a preponderance of
sorbitol  accumulation  and  cataract  in  WNIN/GR-Ob  rats
(with IGT) over WNIN/Ob rats.
However, it is an enigma why only 15%–20% obese
animals in the WNIN/Ob and WNIN/GR-Ob colony develop
cataracts if accumulation of sorbitol is the cause of cataract
formation in these strains. Sorbitol levels could reach or cross
a threshold level to develop cataracts. To substantiate this
assumption, we estimated sorbitol levels in the cataractous
lenses  of  WNIN/Ob  and  WNIN/GR-Ob  rats  at  random.
Sorbitol levels in the cataractous lens of four- to six-month-
old WNIN/Ob and WNIN/GR-Ob rats were between 650 and
750 nmoles/g lens (mean 680 nmoles; n=10), just above the
levels (650 nmoles) as seen in 12-month-old WNIN/Ob and
WNIN/GR-Ob rats (Figure 2). This indicates that sorbitol
levels  above  650  nmoles  may  result  in  cataracts  in  these
animals. Any factor (such as fluctuations in glucose levels,
ALR2  activity,  or  ALR2  expression)  that  abets  or  incites
reaching this threshold level for sorbitol could precipitate
cataract formation. Increased susceptibility of WNIN/Ob and
WNIN/GR-Ob rats to galactose- and streptozotocin-induced
cataract compared to lean rats (P.Y.R., N.V.G., and G.B.R.
unpublished  data)  further  supports  early  onset  and  higher
incidence of cataracts in WNIN/Ob and WNIN/GR-Ob rats.
Although factors other than the increased intracellular glucose
concentrations that cause sorbitol accumulation need to be
identified, these findings are in line with similar observations
made previously in models of nondiabetic conditions and
aging [49,50]. However, since the nature of the genetic lesion
in these rats at present is unknown (work in progress), it is not
possible to directly attribute any pathological process to this
metabolic phenotype. It could be even independently related
to the genotype.
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501In summary, the results indicate that activation of the
sorbitol  pathway  appears  to  enhance  the  risk  of  cataract
development  in  WNIN-obese  rats.  These  rat  models  of
metabolic  syndrome  may  thus  be  valuable  tools  for
investigating obesity-associated cataract and for developing
intervention strategies based on these observations. The data
presented here also imply that there might be a connection
between  increased  sorbitol  levels  and  complications
associated with obesity (or metabolic syndrome), which needs
to be investigated further.
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